Mankind Pharma Ltd vs Sai Life Sciences Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 15, 2026

Key Highlights

The Latest Trading Price of Mankind Pharma Ltd is ₹ 2503 as of 15 May 15:30 . The P/E Ratio of Mankind Pharma Ltd changed from 48.1 on March 2024 to 50.2 on March 2025 . This represents a CAGR of 2.16% over 2 yearsThe P/E Ratio of Sai Life Sciences Ltd changed from 93.4 on March 2025 to 93.4 on March 2025 . This represents a CAGR of 0.00% over 1 years The Market Cap of Mankind Pharma Ltd changed from ₹ 92029 crore on March 2024 to ₹ 99973 crore on March 2025 . This represents a CAGR of 4.23% over 2 yearsThe Market Cap of Sai Life Sciences Ltd changed from ₹ 15883 crore on March 2025 to ₹ 15883 crore on March 2025 . This represents a CAGR of 0.00% over 1 years The revenue of Mankind Pharma Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 3643 crore. This represent the decline of -100% The revenue of Sai Life Sciences Ltd for the Mar '26 is ₹ 617.95 crore as compare to the Dec '25 revenue of ₹ 564.84 crore. This represent the growth of 9.4% The ebitda of Mankind Pharma Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 888.8 crore. This represent the decline of -100% The ebitda of Sai Life Sciences Ltd for the Mar '26 is ₹ 192.36 crore as compare to the Dec '25 ebitda of ₹ 187.94 crore. This represent the growth of 2.35% The net profit of Mankind Pharma Ltd changed from ₹ 543.07 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The net profit of Sai Life Sciences Ltd changed from ₹ -13.5 crore to ₹ 104.24 crore over 8 quarters. This represents a CAGR of NaN% The Dividend Payout of Mankind Pharma Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Sai Life Sciences Ltd changed from 443.82 % on March 2022 to 0 % on March 2025 . This represents a CAGR of -100.00% over 4 years .

About Mankind Pharma Ltd

Mankind Pharma Limited was incorporated on July 3, 1991, as a Private Limited Company with the name 'Mankind Pharma Private Limited', by the Registrar of Companies, Delhi and Haryana, at New Delhi.
Pursuant to conversion of Company to a Public Limited dated July 14, 2005, name of the Company was changed to 'Mankind Pharma Limited' and the RoC issued a fresh Certificate of Incorporation on April 13, 2006. The Company is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations and chronic therapeutic areas across, as well as several consumer healthcare products.
It is present in several acute and chronic therapeutic areas in India, including anti-infectives, cardiovascular, gastrointestinal, anti-diabetic, neuro/CNS, vitamins /minerals / nutrients and respiratory.

About Sai Life Sciences Ltd

Sai Life Sciences Limited was originally incorporated as Sai Dru Syn Laboratories Limited' as a Public Limited Company, dated January 25, 1999, issued by the Registrar of Companies, Andhra Pradesh at Hyderabad.
The Company received the Certificate of Commencement of Business from Registrar of Companies, Andhra Pradesh on February 17, 1999.
Subsequently, the Company name was changed from Sai Dru Syn Laboratories Limited' to Sai Life Sciences Limited' dated December 16, 2003. Thereafter, the name of the Company was changed from Sai Life Sciences Limited' to Sai Advantium Pharma Limited' dated August 30, 2006 issued by the Registrar of Companies, Andhra Pradesh.
Subsequently, the Company name was changed from Sai Advantium Pharma Limited' to Sai Life Sciences Limited' and a fresh Certificate of Incorporation dated May 28, 2012 was issued by the Registrar of Companies, Andhra Pradesh at Hyderabad.

FAQs for the comparison of Mankind Pharma Ltd and Sai Life Sciences Ltd

Which company has a larger market capitalization, Mankind Pharma Ltd or Sai Life Sciences Ltd?

Market cap of Mankind Pharma Ltd is 103,368 Cr while Market cap of Sai Life Sciences Ltd is 23,069 Cr

What are the key factors driving the stock performance of Mankind Pharma Ltd and Sai Life Sciences Ltd?

The stock performance of Mankind Pharma Ltd and Sai Life Sciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Mankind Pharma Ltd and Sai Life Sciences Ltd?

As of May 15, 2026, the Mankind Pharma Ltd stock price is INR ₹2503.9. On the other hand, Sai Life Sciences Ltd stock price is INR ₹1089.3.

How do dividend payouts of Mankind Pharma Ltd and Sai Life Sciences Ltd compare?

To compare the dividend payouts of Mankind Pharma Ltd and Sai Life Sciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.